Alkem Laboratories to open trading window on June 1, 2026
Alkem Laboratories has announced the opening of its trading window for designated persons on June 1, 2026. This follows the communication of the company's financial results for the quarter and year ended March 31, 2026, which were submitted to the stock exchanges on May 28, 2026. The trading window was initially closed on March 30, 2026, to comply with insider trading regulations.

*this image is generated using AI for illustrative purposes only.
Alkem Laboratories will open its trading window for designated persons on June 1, 2026, following the communication of its financial results for the quarter and year ended March 31, 2026. The window was previously closed on March 30, 2026, to comply with insider trading regulations ahead of the results announcement. The company confirmed that the results have now been submitted to the stock exchanges, allowing the trading window to reopen after the mandatory 48-hour period post-disclosure.
The closure of the trading window was a procedural measure implemented to prevent insider trading while the financial results were being finalized. The restriction applied to insiders and designated persons associated with Alkem Laboratories . The reopening of the window permits these individuals to trade in the company's securities once again.
| Event | Date |
|---|---|
| Trading Window Closure | March 30, 2026 |
| Financial Results Communication | May 28, 2026 |
| Trading Window Opening | June 1, 2026 |
The intimation was addressed to the Corporate Relationship Department of BSE Limited and the National Stock Exchange of India Limited. The filing was signed by Manish Narang, President - Legal, Company Secretary & Compliance Officer of Alkem Laboratories Limited.
Historical Stock Returns for Alkem Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.85% | +1.13% | +2.88% | -3.31% | +4.41% | +87.36% |
How will the market react to the financial results now that the trading window has reopened?
What trends in insider trading activity might emerge following the lifting of the restriction?
Could the reopening of the trading window signal a shift in Alkem Laboratories' stock performance in the near term?


































